BrainsWay Ltd. (TLV:BWAY)
3,069.00
-56.00 (-1.79%)
At close: Jan 1, 2026
BrainsWay Market Cap
BrainsWay has a market cap or net worth of 1.2 billion as of December 31, 2025. Its market cap has increased by 77.04% in one year.
Market Cap
1.20B
Enterprise Value
990.09M
Revenue
162.56M
Ranking
n/a
PE Ratio
72.48
Stock Price
3,069.00
Market Cap Chart
Since September 24, 2007, BrainsWay's market cap has increased from 101.45M to 1.20B, an increase of 1,083.84%. That is a compound annual growth rate of 14.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 1.22B | 86.15% |
| Dec 31, 2024 | 656.96M | 72.83% |
| Dec 31, 2023 | 380.12M | 223.68% |
| Dec 29, 2022 | 117.44M | -70.48% |
| Dec 30, 2021 | 397.80M | 56.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 114.15B |
| Danel (Adir Yeoshua) | 2.79B |
| Kamada | 1.30B |
| Bait Bakfar | 1.01B |
| SofWave Medical | 981.37M |
| Ilex Medical | 745.80M |
| Novolog (Pharm-Up 1966) | 641.66M |
| Bonus BioGroup | 293.15M |